Enzootic Revenue and Competitors
Estimated Revenue & Valuation
- Enzootic's estimated annual revenue is currently $5.1M per year.
- Enzootic's estimated revenue per employee is $155,000
Employee Data
- Enzootic has 33 Employees.
- Enzootic grew their employee count by 6% last year.
Enzootic's People
Name | Title | Email/Phone |
---|
Enzootic Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Enzootic?
Enzootic is an animal biotechnology and genetic company based in Singapore with its roots in a business that started in 2012 by a multidisciplinary team of industry and academic leaders whose vision is to introduce the latest advances in life science research to crustacean aquaculture. Based on research from Israel’s Ben-Gurion University of the Negev. The company core intellectual property is a pioneering cell-based technology that taps into the natural sexual plasticity of shrimp to achieve all-female populations, without the use of genetic modification, hormones or chemicals. The company produces and sells high-end, pathogen-free, unique female broodstock, called Super-females, that are only capable of producing female offspring, to freshwater shrimp hatcheries worldwide for superior performance.
keywords:N/AN/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6M | 33 | -43% | N/A |
#2 | $7.5M | 33 | 3% | N/A |
#3 | $4.8M | 33 | 32% | N/A |
#4 | $4.2M | 33 | 6% | N/A |
#5 | $6.7M | 33 | 0% | N/A |